• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Iranian Journal of Pharmaceutical Sciences
Articles in Press
Current Issue
Journal Archive
Volume Volume 13 (2017)
Volume Volume 12 (2016)
Volume Volume 11 (2015)
Volume Volume 10 (2014)
Volume Volume 9 (2013)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 8 (2012)
Volume Volume 7 (2011)
Volume Volume 6 (2010)
Volume Volume 5 (2009)
Volume Volume 4 (2008)
Volume Volume 3 (2007)
Volume Volume 2 (2006)
Volume Volume 1 (2005)
Reddy K, S., A.K, K., Bhava B.S, S., P, S., P, A., E, V. (2013). Lornoxicam Alone and with Selegiline Improves the Neuroprotective Effect and Cognition in Scopolamine Induced Neurodegeneration and Cognitive Impairment in Rats. Iranian Journal of Pharmaceutical Sciences, 9(2), 87-101.
Sainath Reddy K; Kaleem A.K; Sharvana Bhava B.S; Satish P; Aravind P; Venkateshwarlu E. "Lornoxicam Alone and with Selegiline Improves the Neuroprotective Effect and Cognition in Scopolamine Induced Neurodegeneration and Cognitive Impairment in Rats". Iranian Journal of Pharmaceutical Sciences, 9, 2, 2013, 87-101.
Reddy K, S., A.K, K., Bhava B.S, S., P, S., P, A., E, V. (2013). 'Lornoxicam Alone and with Selegiline Improves the Neuroprotective Effect and Cognition in Scopolamine Induced Neurodegeneration and Cognitive Impairment in Rats', Iranian Journal of Pharmaceutical Sciences, 9(2), pp. 87-101.
Reddy K, S., A.K, K., Bhava B.S, S., P, S., P, A., E, V. Lornoxicam Alone and with Selegiline Improves the Neuroprotective Effect and Cognition in Scopolamine Induced Neurodegeneration and Cognitive Impairment in Rats. Iranian Journal of Pharmaceutical Sciences, 2013; 9(2): 87-101.

Lornoxicam Alone and with Selegiline Improves the Neuroprotective Effect and Cognition in Scopolamine Induced Neurodegeneration and Cognitive Impairment in Rats

Article 8, Volume 9, Issue 2, Spring 2013, Page 87-101  XML PDF (355 K)
Document Type: Research Paper
Authors
Sainath Reddy K; Kaleem A.K; Sharvana Bhava B.S; Satish P; Aravind P; Venkateshwarlu E*
Department of Pharmacology, Vaagdevi College of pharmacy, Warangal, INDIA.
Abstract
Alzheimer is a progressive neurodegenerative disorder in which Oxidative stress plays a major role. The present study was designed to investigate Neuroprotective effect of Lornoxicam, Selegiline and co-administration of both drugs in Scopolamine induced cognitive impairment and neurodegeneration. Scopolamine (1.4mg/kg) was administered intraperitoniallyin male Wistar rats. Rectangular maze performance test was used to assess the memory performance test. Various biochemical parameters such as Catalase, 1, 1-diphenyl-2- picrylhydrazine (DPPH), Thiobarbituric acid reactive substances(TBARS), reduced glutathione(GSH) and acetylcholine esterase (AchE) were also assessed. IntraperitonialScopolamine results marked memory impairment and oxidative damage. Sub-acute treatment with Lornoxicam (1.3mg/kg, p.o) and Selegiline (0.49mg/kg, p.o) and co-administration of these two drugs for 8 days significantly attenuated scopolamine induced oxidative damage and neurodegeneration. Besides, Lornoxicam, Selegiline and co-administration of both significantly reversed Scopolamine administered increase in acetylcholine esterase activity. Present study indicates protective effect of Lornoxicam, Selegiline and co-administration of both drugs against Scopolamine induced cognitive impairment and oxidative damage. The memory enhancing capacity of the drugs was very significant when compared with disease control (P <0.001).
Keywords
Alzheimer; AchE; DPPH; GSH; Lornoxicam; Scopolamine; Selegiline; TBARS
Statistics
Article View: 2,548
PDF Download: 1,343
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.